Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
International Journal of Inflammation · 10.03.2022 · 2022 · 1-7
DOI: 10.1155/2022/8632245 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift International Journal of Inflammation, erschienen am 10.03.2022. Verfasst von Shyam Dheda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The origin of this inflammation remains elusive and one putative cause is elevated levels of circulating bacterial endotoxin.
Methods
In this study, serum concentrations of endotoxin and inflammatory biomarkers, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), interleukin-1β (IL1β), ferritin and tumor necrosis factor (TNF), were measured in 30 adults receiving HD and 10 healthy individuals without kidney disease. In people receiving HD, samples were collected immediately before dialysis (preHD), after dialysis (postHD), and 48 hours after (postHD48hrs).
Results
Endotoxin was detectable in only 1 of 90 samples analyzed. There were no significant differences in serum hsCRP, IL1β, and IL6 levels, before and after dialysis. Serum TNF levels decreased significantly from 30.9 (8.0, 39.5) pg/mL preHD to 13.9 (8.5, 17.3) pg/mL post-HD ( p = 0.002 ) and then increased back to 27.37 (14.5, 35) pg/mL 2 days later ( p < 0.001 ). Ferritin increased from 1153 ng/mL (782, 1458) preHD to 1313 ng/mL (657, 1638) post HD ( p < 0.001 ) and then decreased back to 1186 ng/mL (754, 1597) ( p = 0.66 ) postHD48hrs. Compared to controls, people receiving HD had significantly elevated levels of hsCRP [6.16 mg/L (2.1, 16.8) vs. 1.1 mg/L (0.81, 3.63) p = 0.015 ], IL1β [1.5 pg/mL (0.05, 2.51) vs. 0.5 pg/mL (1.81, 2.95) p ≤ 0.001 ], and ferritin [1153 (782, 1458) vs. 132.9 (111, 257) ng/mL p ≤ 0.001 ], but comparable levels of in IL6 [6.15 pg/mL (4.82, 9.12) vs. 7.49 pg/mL (4.56, 10.39), p = 0.77 ] and TNF [27.35 pg/mL ± 17.48 vs. 17.87 pg/mL ± 12.28, p < 0.12 ]. In conclusion, people on HD have elevated levels of inflammatory biomarkers, which are not associated with endotoxemia (which is rare) or the dialysis procedure.
Autor:innen und Institutionen
- Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia.
- Department of Nephrology, Cairns Hospital, Cairns, Queensland, Australia.
- Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
- Translational Research Institute, Brisbane, Australia.
ORCID-Profile: Shyam Dheda
Zitieren
APA
Dheda, S., Vesey, D. A., Hawley, C., Johnson, D. W., & Fahim, M. (2022). Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin. International Journal of Inflammation, 2022, 1-7. https://doi.org/10.1155/2022/8632245
Vancouver
Dheda S, Vesey DA, Hawley C, Johnson DW, Fahim M. Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin. International Journal of Inflammation. 2022;2022:1-7. doi:10.1155/2022/8632245
BibTeX
@article{Dheda2022,
author = {Dheda, Shyam and Vesey, David A and Hawley, Carmel and Johnson, David W and Fahim, Magid},
title = {Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin},
journal = {International Journal of Inflammation},
year = {2022},
volume = {2022},
pages = {1--7},
doi = {10.1155/2022/8632245}
}
EUVIMED